Go to content
Esperite N.V.

Esperite N.V.

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 03 nov 2015 - 07:17
Statutaire naam Esperite N.V.
Titel ESPERITE N.V. Trading Update. CryoSave stable, Genoma 45% growth
Bericht Zutphen, The Netherlands - 3 November 2015 ESPERITE N.V. (Euronext: ESP, 'ESPERITE', or 'the Group') announces its trading update for the quarter ended 30 September 2015. ESPERITE keeps growing at an incremental pace and the prospects for Q4 remain positive. Consolidated revenue increased in Q3 over the same period of last year by 5%. High-profile agreements with some of the largest, most prestigious and influential health institutions in Europe are starting to bear fruit. Increased visibility and strong brand awareness has been attained throughout the targeted European markets.

Datum laatste update: 19 april 2024